White Matter Pathology as a Barrier to Gangliosidosis Gene Therapy
The gangliosidoses are a family of neurodegenerative lysosomal storage diseases that have recently seen promising advances in gene therapy. White matter deficits are well established components of gangliosidosis pathology that are now receiving more attention because they are partially refractory to...
Main Authors: | Anne S. Maguire, Douglas R. Martin |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-08-01
|
Series: | Frontiers in Cellular Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fncel.2021.682106/full |
Similar Items
-
An Evalution of the Demographic and Clinical Characterictics of Patients with GM2 Gangliosidosis
by: Esra Er, et al.
Published: (2018-03-01) -
Investigating Immune Responses to the scAAV9-<i>HEXM</i> Gene Therapy Treatment in Tay–Sachs Disease and Sandhoff Disease Mouse Models
by: Shalini Kot, et al.
Published: (2021-06-01) -
Infantile onset Sandhoff disease: clinical manifestation and a novel common mutation in Thai patients
by: Thipwimol Tim-Aroon, et al.
Published: (2021-01-01) -
From amaurotic idiocy to biochemically defined lipid storage diseases: the first identification of GM1-Gangliosidosis
by: Burkhard S Kasper, et al.
Published: (2023-08-01) -
From amaurotic idiocy to biochemically defined lipid storage diseases: the first identification of GM1-Gangliosidosis
by: Burkhard S Kasper, et al.
Published: (2023-08-01)